| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/19/2005 | CN1565582A Chinese medicine formulation with functions of resisting senescence and preventing and treating posteoporosis and cerebral lesion |
| 01/19/2005 | CN1565555A Antisenescence Chinese drug |
| 01/19/2005 | CN1565518A Prescription of pediluvium and its preparation method |
| 01/19/2005 | CN1565458A Tomatine preparation for prevention and cure of tissue and organ fibrosis |
| 01/19/2005 | CN1565433A Hypocrellin water-soluble nanogranule and its uses |
| 01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185257C Glucagon insulinotropic complexes, compositions and methods |
| 01/19/2005 | CN1185247C Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185226C Intermediate for preparing benzothiophene amide derivate |
| 01/19/2005 | CN1185220C Para-amino substituted phenylamide glucokinase activators |
| 01/19/2005 | CN1185219C Trans olefinic glucokinase activators |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185214C Novel indeno indolone compound, its preparation method and drug composition comprising the same |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185000C Medicine for treating cyst |
| 01/19/2005 | CN1184992C Chinese patent medicine for treating paraplegia |
| 01/19/2005 | CN1184964C Use of carbonylamino derivatives against CNS disorders |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/19/2005 | CN1184958C Erythropoietin Liposomal dispersion |
| 01/19/2005 | CN1184957C Intravaginal drug delivery devices for adminsitration of testosterone and testosterone precursors |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/18/2005 | US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 01/18/2005 | US6844445 Central nervous system disorders; psychological disorders |
| 01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/18/2005 | US6844429 Fullerene derivative and composition comprising the same |
| 01/18/2005 | US6844366 Such as N-hydroxy-2(R)-((3,4-methylenedioxybenzyl)-(4-methoxy-2,3,6-trimethylbenzene-sulfonyl) amino)-3-methylbutyramide for treatment of diseases treatable with pro-collagen C-proteinase inhibitors |
| 01/18/2005 | US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
| 01/18/2005 | US6844351 Corticotropin releasing factor antagonists |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844345 Piperazine derivatives |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/18/2005 | US6844340 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 01/18/2005 | US6844337 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, their preparation and their application in therapeutics |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844314 Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6843800 Patient temperature regulation method and apparatus |
| 01/18/2005 | CA2367127C Macrocyclic peptides active against the hepatitis c virus |
| 01/18/2005 | CA2149324C Fluidized intestinal submucosa and its use as an injectable tissue graft |
| 01/13/2005 | WO2005002672A2 Sirt1 modulators for manipulating cells/organism lifespan/stress response |
| 01/13/2005 | WO2005002589A1 Improvement of the hatching ability of egg-laying animals |
| 01/13/2005 | WO2005002563A2 Method for treating alcoholic hepatitis |
| 01/13/2005 | WO2005002555A2 Sirt1 modulators for manipulating cell/organism lifespan/stress response |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2003089569A3 Use of il-19, il-22 and il-24 to treat hematopoietic disorders |
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010050 Antiinflammatory agents; antiarthritic agents; anticancer agents; analgesics |
| 01/13/2005 | US20050010048 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050009925 Administering atomoxetine or its hydrochloride or a 3-(o-alkylthiophenoxy)-3-phenyl-N-alkylpropylamine for the treatment of cognitive failure, including that due to dementia, delirium and schizophrenia |
| 01/13/2005 | US20050009920 Taxol enhancer compounds |
| 01/13/2005 | US20050009914 Increasing the production of the blood-forming hormone erythropoietin, especially for the treatment of aging- or disease-related conditions associated with decreased oxygen supply to the tissue, especially in elderly subjects, in the treatment of malignant diseases and in cardiorespiratory disorders |
| 01/13/2005 | US20050009898 New substituted indolinones, their manufacture and their use as medicaments |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009872 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009852 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 01/13/2005 | US20050009846 2,6,9-Substituted purine derivatives and their use in the treatment of proliferative disorders |
| 01/13/2005 | US20050009845 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 01/13/2005 | US20050009843 Thiazole derivatives of pyrido-1,2-a-pyrimidines, quinolones, pyridopyridazinoness, cinnolinones and naphthyridones; identifying a drug efflux pump expressed in a microorganism |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009831 Chemical compounds |
| 01/13/2005 | US20050009826 5,6,13-trizaza- or 6,13-diazachryseno[2,3-d]-[1,3]dioxole derivatives; enzyme inhibitors; anticarcinogenic, antiproliferative agents; bactericides, fungicides |
| 01/13/2005 | US20050009824 Solubilized topoisomerase poisons |
| 01/13/2005 | US20050009822 7-(1-Acetylpentyl)-5-methyl-2-(4-methylbenzyl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; learning enhancement, concentration power, learning power, memory power; enzyme inhibitors of phosphodiesterase isoenzyme |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009814 Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist |
| 01/13/2005 | US20050009808 Azabicyclo compound matrix metalloprotease inibitor and skin preparation |
| 01/13/2005 | US20050009807 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 01/13/2005 | US20050009802 Tertiary amino-substituted, e.g, 1(4),8(11),15(18),22(25)-tetrakis[(3-(dimethylamino)phenoxy)phthalocyaninato] zinc; and their use as photodynamic therapeutic and photodiagnostic agents. |
| 01/13/2005 | US20050009787 Complex of phosphate and ubiquinone, ascorbic acid, retinol, tocotriennol in mixture with carrier |
| 01/13/2005 | US20050009779 Preparation for improving the action of receptors |
| 01/13/2005 | US20050009778 Method for treating retinal degeneration with purinergic receptor agonists |
| 01/13/2005 | US20050009775 Hepatitis c virus; viricides |
| 01/13/2005 | US20050009759 Anticancer agents |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009751 Pentapeptide compounds and uses related thereto |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009062 Phosphodiesterase 10 |
| 01/13/2005 | US20050008688 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 01/13/2005 | US20050008653 In situ binding of polypeptide to stabilizer; induction apoptosis |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | CA2530480A1 Conjugated complement cascade inhibitors |
| 01/13/2005 | CA2529510A1 Sirt1 modulators for manipulating cells/organism lifespan/stress response |
| 01/13/2005 | CA2528913A1 Method for treating alcoholic hepatitis |